Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κB

被引:0
作者
Ji-Woong Kwon
Hyuk-Kwon Kwon
Hyeon-Jun Shin
Yong-Min Choi
Muhammad Ayaz Anwar
Sangdun Choi
机构
[1] Ajou University,Department of Molecular Science and Technology
来源
Scientific Reports | / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Activating transcription factor 3 (ATF3) is induced by inflammatory responses, cell death, cytokines and oxidative stress conditions. ATF3 is a negative regulator in the Toll-like receptor 4 signalling pathway. The principal molecule in this pathway is nuclear factor κB (NF-κB) that translocates into the nucleus to initiate the transcription of inflammatory mediators. However, scarce data are available regarding the interaction of ATF3 and p65, a part of the NF-κB dimer. Therefore, we studied the mechanism of regulation of p65 by ATF3 in RAW 264.7 cells. First, LPS-mediated NF-κB activation was confirmed and then the direct interaction of ATF3 and p65 was observed through immunoprecipitation (IP). The presence of histone deacetylase 1 (HDAC1) was also detected in the complex. In ATF3 deficient cells, NF-κB activity was up-regulated and HDAC1 was not detected by IP. These observations suggest that p65 is attenuated by ATF3 such that ATF3 recruits HDAC1 to the ATF3/p65 complex and facilitates the deacetylation of p65. Likewise, inflammatory response genes were induced by translocated NF-κB in ATF3-deficient cells. Cumulatively, we uncovered a novel mechanism for the negative regulation of NF-κB by ATF3 via direct interaction with p65.
引用
收藏
相关论文
共 118 条
[1]  
Kaisho T(2006)Toll-like receptor function and signaling J Allergy Clin Immunol 117 979-987
[2]  
Akira S(2007)Toll-like receptor signal transduction Exp Mol Med 39 421-438
[3]  
Krishnan J(2011)Toll-like receptor modulators: a patent review (2006–2010) Expert Opin Ther Pat 21 927-944
[4]  
Selvarajoo K(2006)The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity J Immunol 176 157-164
[5]  
Tsuchiya M(2001)Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses Cancer Immunol Immunother 50 503-514
[6]  
Lee G(2009)Drugs targeting Toll-like receptors Arch Pharm Res 32 1485-1502
[7]  
Choi S(2002)Missing pieces in the NF-kappaB puzzle Cell 109 S81-96
[8]  
Basith S(1994)Structure, regulation and function of NF-kappaB Annu Rev Cell Biol 10 405-455
[9]  
Manavalan B(1995)Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation Genes Dev 9 2723-2735
[10]  
Lee G(2004)Signaling to NF-kappaB Genes Dev 18 2195-2224